Related Experiment Videos

Microbody (peroxisome) proliferation in mouse kidney induced by methyl clofenapate

Virchows Archiv. B, Cell Pathology
|January 1, 1975
PubMed

Insights

Methyl clofenapate, a hypolipidemic drug, significantly increased peroxisomes in mouse kidney tubules. Further research is needed to determine if this impacts renal function.

Area of Science:

  • Biochemistry
  • Toxicology
  • Cell Biology

Background:

  • Methyl clofenapate is a hypolipidemic compound.
  • The effects of methyl clofenapate on kidney structure are not fully understood.

Purpose of the Study:

  • To investigate the effects of methyl clofenapate on kidney morphology in mice.
  • To identify specific organelles affected by methyl clofenapate treatment.

Main Methods:

  • Male wild type mice were fed a diet containing 0.03% methyl clofenapate for 2-5 weeks.
  • Kidney tissues were examined using electron microscopy.
  • Catalase activity was localized cytochemically to identify peroxisomes.

Main Results:

  • A significant increase in single membrane-limited organelles, identified as peroxisomes, was observed in proximal convoluted tubule cells (P1, P2, P3 segments).
  • No increase in lysosomes was detected in the renal tubules of treated mice.

Conclusions:

  • Methyl clofenapate administration leads to a notable proliferation of peroxisomes in mouse renal proximal tubules.
  • The functional consequences of this peroxisome increase on renal function remain uncertain.

Related Concept Videos